Diagnostic Difficulties of Mucopolysaccharidosis Type I Mild Forms: Clinical Cases

Diagnostic Difficulties of Mucopolysaccharidosis Type I Mild Forms: Clinical Cases

Mucopolysaccharidosis type I mild forms include Scheie syndrome and Hurler-Scheie syndrome that are characterized by slow progression, intact intelligence, and primarily effect on visual organ, musculoskeletal and cardiovascular systems. Early diagnostics, multidisciplinary approach to examination a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nato D. Vashakmadze, Leyla S. Namazova-Baranova, Natalia V. Zhurkova, Ekaterina Yu. Zakharova, Elena J. Voskobaeva, Marina A. Babaikina, Lyudmila M. Mikhaylova
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2020-06-01
Series:	Вопросы современной педиатрии
Subjects:	mucopolysaccharidosis scheie syndrome hurler-scheie syndrome alpha-l-iduronidase diagnostics
Online Access:	https://vsp.spr-journal.ru/jour/article/view/2379
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Orthopedic Pathology in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2016-12-01)

Articular Syndrome Characteristics in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2021-12-01)

Mucopolysaccharidosis Type I (Hurler – Scheie Syndrome): Case Report
by: Nato D. Vashakmadze, et al.
Published: (2024-09-01)

Differential Diagnosis of Hurler and Hurler–Scheie Syndromes: Clinical Case
by: Nataliya V. Buchinskaya, et al.
Published: (2025-05-01)

Antibodies to recombinant human alpha-L-iduronidase prevent disease correction in cortical bone in MPS I mice
by: Sarah C. Hurt, et al.
Published: (2025-03-01)

Rare cases of mucopolysaccharidosis type I in children with Hurler and Hurler-Scheie syndromes
by: A. E. Babushkin, et al.
Published: (2018-10-01)

Scheie Syndrome Diagnosis in Early Childhood: Case Study
by: Nataliya V. Buchinskaya, et al.
Published: (2025-07-01)

Combination Treatment for Severe Forms of Mucopolysaccharidosis, Type I (Hurler Syndrome): Case Report
by: Nato V. Vashakmadze, et al.
Published: (2023-12-01)

Imaging hallmarks of mucopolysaccharidosis in a young Ethiopian boy: A case report
by: Muluken Yifru Gebresilassie, MD, et al.
Published: (2025-09-01)

Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation Results in Patients with Hurler Syndrome: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2019-09-01)

Mucopolisacaridosis (síndrome de Hunter)
by: Xidix Toirac Cabrera, et al.

Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020-02-01)

Results of 14-year-long Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II: Clinical Case
by: Natalia V. Zhurkova, et al.
Published: (2023-01-01)

Idursulfase Beta (Hunterase) Therapeutic Experience in a Patient with Mucopolysaccharidosis Type II
by: Nato D. Vashakmadze, et al.
Published: (2023-08-01)

How to Distinguish Attenuated Forms of Mucopolysaccharidosis and Articular Forms of Juvenile Arthritis: Development of Diagnostic Algorithm Based on the Data from Multicenter Retrospective Study
by: Natalia V. Buchinskaya, et al.
Published: (2023-01-01)

EFFECTIVENESS OF MODERN METHODS OF TREATING TYPE I MUCOPOLYSACCHARIDOSIS PATIENTS
by: L. S. Namazova-Baranova, et al.
Published: (2014-11-01)

Enzyme Replacement Therapy with Idursulfase in Patients with Mucopolysaccharidosis Type II: Literature Review
by: Nato D. Vashakmadze, et al.
Published: (2021-12-01)

Non-Neuropathic Form of Mucopolysaccharidosis Type II: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2021-03-01)

Intracerebroventricular Enzyme Replacement Therapy in Patients with Neuropathic Form of Mucopolysaccharidosis Type II: to Help Practicing Physician
by: Nataliya V. Zhurkova, et al.
Published: (2024-09-01)

Clinical Characteristics of a Patient with Mucopolysaccharidosis Type IVA (Morquio Syndrome)
by: Nato D. Vashakmadze, et al.
Published: (2023-01-01)

Clinical Case of Drug Allergy to Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II
by: Julia G. Levina, et al.
Published: (2022-07-01)

Allergic Reactions at Enzyme Replacement Therapy in Children with Mucopolysaccharidosis Type II
by: Julia G. Levina, et al.
Published: (2021-12-01)

Neuroradiological Characteristics in Patients with Mucopolysaccharidosis Type II: A Systematic Review
by: Yancarlos Ramos-Villegas, et al.
Published: (2023-02-01)

Modern Approaches to the Management of Children with Mucopolysaccharidosis Type I
by: Galina V. Baidakova, et al.
Published: (2022-10-01)

CARDIOVASCULAR PATHOLOGY IN CHILDREN WITH TYPE I MUCOPOLYSACCHARIDOSIS
by: N. D. Vashakmadze, et al.
Published: (2014-07-01)

EFFICACY AND SAFETY OF ENZYME REPLACEMENT THERAPY IN CHILDREN WITH MUCOPOLYSACCHARIDOSIS TYPE I, II, AND VI: A SINGLE-CENTER COHORT STUDY
by: Liliia A. Osipova, et al.
Published: (2018-04-01)

Early Diagnosis and Results of Enzyme Replacement Therapy in the Patient with Mucopolysaccharidosis Type VI: Clinical Case
by: Dmitry V. Ivanov, et al.
Published: (2021-12-01)

Unmet needs of adults living with mucopolysaccharidosis II: data from the Hunter Outcome Survey
by: Joseph Muenzer, et al.
Published: (2025-07-01)

Mucopolysaccharidosis: A rare case from ophthalmology perspective
by: Santosh Singh Patel, et al.
Published: (2025-01-01)

Electromyography in diagnostic of median nerve lesion in carpal tunnel syndrome of children with mucopolysaccharidoses
by: A. L. Kurenkov, et al.
Published: (2015-02-01)

Mucopolysaccharidosis type IVA and severe hidradenitis suppurativa: A case series
by: Jorga Fialová, MD, et al.
Published: (2025-08-01)

How Not to Miss the Mild Forms of Mucopolysaccharidosis Type I in Patients With Articular Manifestations of the Disease?
by: Natalia V. Buchinskaya, et al.
Published: (2019-01-01)

Neurodegeneration and aging pathways in Mucopolysaccharidosis IIIB
by: Yorran Hardman Araújo Montenegro
Published: (2025-07-01)

Rare Case of Morquio Syndrome (Mucopolysaccharidosis Type IVA): Difficulties of Diagnostic Search and Management
by: Yulia P. Semschikova, et al.
Published: (2022-03-01)

Oral manifestation and root canal therapy of the patient with mucopolysaccharidosis
by: Ji-Hye Yoon, et al.
Published: (2019-05-01)

Current Approaches to the Treatment of Hunter Syndrome
by: Ekaterina Yu. Zakharova, et al.
Published: (2018-10-01)

Molecular basis of mucopolysaccharidosis type II (Hunter syndrome): first review and classification of published IDS gene variants
by: Alessandra Zanetti, et al.
Published: (2024-12-01)

MODERN APPROACHES TO THERAPY FOR CHILDREN WITH MUCOPOLYSACCHARIDOSIS
by: N. V. Buchinskaya, et al.
Published: (2014-05-01)

Efficacy and safety of a biosimilar laronidase versus the reference laronidase in patients with mucopolysaccharidosis type I
by: Ali Rabbani, et al.
Published: (2025-08-01)

Damages of Cardiovascular System at Mucopolysaccharidosis Type I: Clinical Cases
by: Elena S. Vasichkina, et al.
Published: (2020-01-01)